IDEX Corp Files 8-K Report

TL;DR

IDEX Corp filed an 8-K on 9/17, check it for new disclosures.

AI Summary

On September 17, 2025, IDEX Corporation filed an 8-K report to disclose information under Regulation FD and other events. The filing includes financial statements and exhibits, with the report being filed as of September 18, 2025. The company is incorporated in Delaware and its principal executive offices are located in Northbrook, Illinois.

Why It Matters

This 8-K filing serves as an official notification to the public and investors regarding significant corporate events or disclosures by IDEX Corporation.

Risk Assessment

Risk Level: low — This filing is a routine disclosure and does not appear to contain any immediately alarming or negative information.

Key Numbers

• 001-10235 — SEC File Number (Identifies the company's filing history with the SEC.)
• 36-3555336 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

• IDEX CORP /DE/ (company) — Registrant
• September 17, 2025 (date) — Date of earliest event reported
• September 18, 2025 (date) — Date of Report / Filed as of Date
• Delaware (jurisdiction) — State of incorporation
• Northbrook, Illinois (location) — Principal executive offices
• 3100 Sanders Road, Suite 301 (address) — Business and Mail Address

FAQ

Key Financial Figures

• $635 million — horized the repurchase of an additional $635 million of the Company's common shares. The inc
• $365 million — zation, when added to the approximately $365 million that remained available from the previo
• $1 billion — epurchase availability of approximately $1 billion. The repurchases will be made from ti

Filing Documents

• iex-20250917.htm (8-K) — 29KB
• iex-20250918xex991.htm (EX-99.1) — 7KB
• iex-20250918xex991001.jpg (GRAPHIC) — 233KB
• iex-20250918xex991002.jpg (GRAPHIC) — 317KB
• 0000832101-25-000034.txt ( ) — 915KB
• iex-20250917.xsd (EX-101.SCH) — 2KB
• iex-20250917_lab.xml (EX-101.LAB) — 22KB
• iex-20250917_pre.xml (EX-101.PRE) — 13KB
• iex-20250917_htm.xml (XML) — 3KB

01 - Regulation FD Disclosure

Item 7.01 - Regulation FD Disclosure. A copy of the press release relating to the matter described below is attached hereto as Exhibit 99.1 and is furnished herewith.

01 - Results of Operations and Financial Condition

Item 8.01 - Results of Operations and Financial Condition. On September 17, 2025, the Board of Directors of IDEX Corporation (the "Company") authorized the repurchase of an additional $635 million of the Company's common shares. The increased repurchase authorization, when added to the approximately $365 million that remained available from the previously approved repurchase authorizations, provides the Company with a total authorized repurchase availability of approximately $1 billion. The repurchases will be made from time to time in either open market transactions or in privately negotiated transactions, and may also be made under 10b5-1 plans. The timing, volume and nature of share repurchases will be at the discretion of management, dependent on market conditions, other priorities of cash investment, applicable securities laws and other factors. This share repurchase program does not obligate the Company to acquire any particular amount of common stock, and it may be suspended or discontinued at any time.

01 – Financial Statements and Exhibits

Item 9.01 – Financial Statements and Exhibits. (d) Exhibits 99.1 Press release dated September 18, 2025 announcing IDEX Corporation's additional share repurchase authorization. . 104.0 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IDEX CORPORATION By: /s/ AKHIL MAHENDRA Akhil Mahendra Interim Chief Financial Officer and Vice President, Corporate Development September 18, 2025

View Full Filing

View this 8-K filing on SEC EDGAR